Creating new complex molecules for potential drug development
Rapid Synthesis of Topologically Complex Molecules with Tungsten Dearomatization Agents
This study is exploring new ways to create complex molecules that could help in making better medicines, using a special technique to change simple compounds into more useful ones for drug discovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11038259 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods to synthesize complex molecules that could lead to new pharmaceutical agents. By using tungsten dearomatization agents, the team aims to transform simple aromatic compounds like benzene into more complex structures that can be explored for their medicinal properties. The approach involves adding various chemical fragments to these newly formed structures, potentially expanding the range of compounds available for drug discovery. This work could significantly enhance the diversity of molecules that medicinal chemists can work with in developing new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from new pharmaceutical agents developed from these complex molecules.
Not a fit: Patients who are not seeking new treatment options or those with conditions that are not addressed by the types of drugs being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drugs that are more effective in treating various diseases.
How similar studies have performed: Previous research has shown success in developing new synthetic methods for complex molecules, indicating a promising avenue for drug discovery.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Harman, Walter Dean — University of Virginia
- Study coordinator: Harman, Walter Dean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.